Specialty Drugs' Impact On Your Self-Insured Plan
Facebook LinkedIn Twitter New User? REGISTER NOW LOG IN MEDICAL OVERBILLING COSTS BILLIONS SALES 301-960-7092|GENERAL 301-381-1398 HOME ABOUT NEWS SERVICES SUCCESS CONTACT SPECIALTY DRUGS' IMPACT ON YOUR SELF-INSURED PLAN By: Bruce Roffé, President and CEO of HHC Group Featured on The Employer's Guide to Self-Insuring Health Benefits Like most businesses, self-insured employer groups are desperately seeking ways to reduce healthcare costs – and it's no secret prescription drugs make up a significant chunk of those costs. If you look more closely, specialty drugs emerge as a main culprit. These high-cost meds made up less than one-percent of all written prescriptions in 2014, but accounted for 32-percent of all drug expenditures, according to research by Express Scripts. Fortunately, your self-insured plan can address the impact specialty drugs have on your healthcare costs, but it's important to first understand what they are and how they're being used by your employees and their f
Specialty Drugs' Impact On Your Self-Insured Plan ⚠ Our website systems will undergo updates from 4pm Eastern on Friday (3/24) until Monday (3/27). Please send all Independent Medical Review reports or new claims to mrp@hhcgroup.com . Cost Containment Claims: referrals@hhcgroup.com Or call, 301-813-6016 for assistance. --> Facebook LinkedIn Twitter New User? Register now Log in Contact Medical Overbilling Costs Billions --> SALES 240-813-6016 | GENERAL 800-836-8681 Home About Company Overview The HHC Difference Executive Team Partners and PPO Networks Careers FAQs News Press Releases Blo
Explore this link on the map →related reading
- Tackling Specialty Drug Affordability: Empowering Employersnashcares.com
- Inside the Mafia of Pharma Pricing - BIG by Matt Stollerthebignewsletter.com
- 392: Someone Else's Money - This American Lifethisamericanlife.org
- How Paytient Pays for Itselfpaytient.com
- The Fiduciary Obligation to Avoid 56,000% Markups on Rxgottwals.substack.com
- The Ozempocalypse Is Nigh - by Scott Alexanderastralcodexten.com
- Joe Biden Lowered Drug Prices. Does Anyone Care? - The Atlantictheatlantic.com
- How PBMs can use private-labelled drug products as a great escape from anti-steering policies - 46brooklyn Research46brooklyn.com
- Breaking Down Health Plan Fees - by Jan-Felix Schneiderhealthtechstack.io
- Virtue | Hypothesis - A New Actuarial Infrastructure Layer Is Emergingvirtuevc.com
- Understanding Drug Pricing from Divergent Perspectives: State of Washington Prescription Drug Pricing Analysis - 3 ∆XIS Advisors3axisadvisors.com
- What a time to be an oncologist - by Olivia Webb Kosloffacutecondition.com